Puma Biotechnology (PBYI) Restructuring Costs (2012)

Puma Biotechnology (PBYI) reported Restructuring Costs of $12.0 million for Q4 2012, up 84.62% quarter-over-quarter from $6.5 million in Q3 2012.

Puma Biotechnology (PBYI) Restructuring Costs (2012) Analysis & Trends

Puma Biotechnology has reported Restructuring Costs for 1 years, with the latest figure at $12.0 million in Q4 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Puma Biotechnology	384.39 Mn	282.84 Mn	34.39 Mn

Download Data